학술논문
P49 The efficacy and safety of Tideglusib in a randomized, placebo-controlled, double blind study in children and adolescents with congenital myotonic dystrophy (REACH CDM study)
Document Type
Abstract
Author
Source
In Neuromuscular Disorders October 2023 33 Supplement 1:S70-S71
Subject
Language
ISSN
0960-8966